SEC Form 4 · accession 0001127602-19-010919
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph W LaPlume
Officer — EVP, Corp Strategy & Develop
Period of report
Mar 8, 2019
Accepted (ET)
Mar 12, 2019 · 7:57 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 8, 2019 | M | 1,542 | $76.67 | A | 16,325 | D | |
| Common Stock | Mar 8, 2019 | M | 3,350 | $73.70 | A | 19,675 | D | |
| Common Stock | Mar 8, 2019 | M | 3,492 | $88.05 | A | 23,167 | D | |
| Common Stock | Mar 8, 2019 | M | 3,204 | $109.34 | A | 26,371 | D | |
| Common Stock | Mar 8, 2019 | S | 200 | $137.415 | D | 26,171 | D | |
| Common Stock | Mar 8, 2019 | S | 100 | $137.43 | D | 26,071 | D | |
| Common Stock | Mar 8, 2019 | S | 198 | $137.44 | D | 25,873 | D | |
| Common Stock | Mar 8, 2019 | S | 302 | $137.45 | D | 25,571 | D | |
| Common Stock | Mar 8, 2019 | S | 400 | $137.46 | D | 25,171 | D | |
| Common Stock | Mar 8, 2019 | S | 400 | $137.48 | D | 24,771 | D | |
| Common Stock | Mar 8, 2019 | S | 100 | $137.495 | D | 24,671 | D | |
| Common Stock | Mar 8, 2019 | S | 200 | $137.515 | D | 24,471 | D | |
| Common Stock | Mar 8, 2019 | S | 308 | $137.53 | D | 24,163 | D | |
| Common Stock | Mar 8, 2019 | S | 300 | $137.56 | D | 23,863 | D | |
| Common Stock | Mar 8, 2019 | S | 100 | $137.58 | D | 23,763 | D | |
| Common Stock | Mar 8, 2019 | S | 164 | $137.605 | D | 23,599 | D | |
| Common Stock | Mar 8, 2019 | S | 330 | $137.63 | D | 23,269 | D | |
| Common Stock | Mar 8, 2019 | S | 300 | $137.64 | D | 22,969 | D | |
| Common Stock | Mar 8, 2019 | S | 6 | $137.665 | D | 22,963 | D | |
| Common Stock | Mar 8, 2019 | S | 100 | $137.71 | D | 22,863 | D | |
| Common Stock | Mar 8, 2019 | S | 200 | $137.72 | D | 22,663 | D | |
| Common Stock | Mar 8, 2019 | S | 500 | $137.73 | D | 22,163 | D | |
| Common Stock | Mar 8, 2019 | S | 100 | $137.735 | D | 22,063 | D | |
| Common Stock | Mar 8, 2019 | S | 200 | $137.74 | D | 21,863 | D | |
| Common Stock | Mar 8, 2019 | S | 100 | $137.75 | D | 21,763 | D | |
| Common Stock | Mar 8, 2019 | S | 100 | $137.76 | D | 21,663 | D | |
| Common Stock | Mar 8, 2019 | S | 100 | $137.77 | D | 21,563 | D | |
| Common Stock | Mar 8, 2019 | S | 300 | $137.80 | D | 21,263 | D | |
| Common Stock | Mar 8, 2019 | S | 114 | $137.81 | D | 21,149 | D | |
| Common Stock | Mar 8, 2019 | S | 300 | $137.82 | D | 20,849 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $76.67 | Mar 8, 2019 | M | 1,542 | D | Feb 27, 2016 | Feb 27, 2020 | Common Stock | 1,542 | 0 | D |
| Stock Options (Right to Buy) | $73.70 | Mar 8, 2019 | M | 3,350 | D | Feb 26, 2017 | Feb 26, 2021 | Common Stock | 3,350 | 3,350 | D |
| Stock Options (Right to Buy) | $88.05 | Mar 8, 2019 | M | 3,492 | D | Feb 24, 2018 | Feb 24, 2022 | Common Stock | 3,492 | 6,985 | D |
| Stock Options (Right to Buy) | $109.34 | Mar 8, 2019 | M | 3,204 | D | Feb 23, 2019 | Feb 23, 2023 | Common Stock | 3,204 | 9,614 | D |